期刊文献+

HLAMatchmaker软件在HLA配型中的应用原理及前景 被引量:2

Principles and application prospect of HLAMatchmaker in the HLA matching
原文传递
导出
摘要 随着分子生物学技术的发展,HLA基因序列、氨基酸序列及蛋白质晶体空间结构逐步明确,使得可以运用计算机生物信息方法在移植术前HLA配型中发挥更为有效的作用。HLAMatchmaker软件是基于Excel软件开发,通过对供、受者HLA抗原氨基酸序列上的eplets进行比较,寻找合适的供者,提高移植术后受者生存率。运用此软件分析可避开基因错配位点,让群体反应性抗体高敏感性受者亦能接受移植。本文就HLAMatchmaker软件在HLA配型中的应用原理及前景展开综述。 With the development of molecular biology technology, the sequences of DNA and the amino acid and protein crystal structure of HLA are explicit. These advances facilitate the use of bioinformatics tools to play a more effective role in matching HLA between donors and recipients before transplantation. HLAMatchmaker is an Excel-based algorithm which determines donor-recipient HLA eplets of amino acid sequence, so as to find a suitable donor to improve the survival of allograft. In addition, HLAMatchmaker algorithm can avoid mismatch locus, and panel reaction antibody high sensitivity patients also can accept transplants. We reviewed the principles, and application prospect of HLAMatehmaker in transplantation.
出处 《中华移植杂志(电子版)》 CAS 2013年第1期34-39,共6页 Chinese Journal of Transplantation(Electronic Edition)
基金 浙江省自然科学基金(LY12H10004) 温州市科技局基金(H20100070)
关键词 HLAMATCHMAKER 表位 群体反应性抗体 HLAMatchmaker Epitope Panel reaction antibody
  • 相关文献

参考文献20

  • 1Duquesnoy RJ. HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients. Transplant Proc, 2001,33(1-2) :493-497.
  • 2Varnavidou- Nicolaidou A, Doxiadis II, Iniotaki- Theodoraki A, et al. HLA class I donor-specific triplet antibodies detected after renal transplantation. Transplant Proc, 2004,36 (6) : 1732-1734.
  • 3Duquesnoy RJ. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications. Tissue Antigens, 2011,77 (6) :525-534.
  • 4Duquesnoy R J, Awadalla Y, Lomago J, et al. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR, DQ, DP epitopes. Transpl Immunol, 2008, 18 (4) :352-560.
  • 5Duquesnoy RJ, Marrari M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. 11. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Hum Immunol, 2002,63 ( 5 ) : 353- 363.
  • 6Duquesnoy R J, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol, 2007,68(1) : 12-25.
  • 7Duquesnoy R J, Howe J, Takemoto S. HLAmatchmaker : molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Transplantation, 2003,75 (6) :889-897.
  • 8Duquesnoy R J, Takemoto S, de Lange P, et al. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. Ⅲ. Effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival. Transplantation, 2003,75 (6) : 884-889.
  • 9Tong JY, Hsia S, Parris GL, et al. Molecular compatibility and renal graft survival-the HLA DQB1 genotyping. Transplantation, 1993, 55 (2) :390-395.
  • 10Duquesnoy RJ. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ Tansplantation. Curt Opin Immunol, 2008,20(5 ) :594-601.

同被引文献36

  • 1童军,李岩,杨文冲,王宏,刘颖,李勇.ABO免疫磁珠反定型试剂自动化检测方法的建立[J].中国输血杂志,2007,20(1):40-41. 被引量:4
  • 2Duquesnoy RJ. HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients [J]. Transplant Proc, 2001, 33(1-2): 493-497.
  • 3Duquesnoy RJ, Takemoto S, de Lange P, et al. HLAmatch- maker: a molecularly based algorithm for histocompatibility determination. Ⅲ. Effect of matching at the HLA-A, B amino acid triplet level on kidney transplant survival [ J]. Trans- plantation, 2003, 75(6): 884-889.
  • 4Dankers MK, Witvliet MD, Roelen DL, et al. The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched hu- man leukocyte antigens [ J ]. Transplantation, 21X)4, 77 (8) : 1236-1239.
  • 5Thompson JS, Thacker LR. CREG matching for first cadaver- ic kidney transplants (TNX) performed by SEOPF centers be- tween October 1987 and September 1995. Southeastern Organ Procuremem Foundation [J]. Clin Transplant, 1996, 10(6 Pt 2) : 586-593.
  • 6Valentini RP, Nehlsen-Cannarella SL, Gnlber SA, et al. In- travenous immunoglobulin, HLA allele typing and HLAMatch- maker facilitate successful transplantation in highly sensitized pediatric renal allograft recipients [ J]. Pediatr Transplant,2007, 11(1): 77-81.
  • 7Crowe DO. The effect of eross-reaetive epitope group match- ing on allocation and sensitization [ J ]. Clin Transplant, 2003, 17 (Suppl 9) : 13-16.
  • 8Mizutani K, Terasaki P, Hamdani E, et al. The importance of anti-HLA-specitic antibody strength in monitoring kidney transplant patients [ J ]. Am J Transplant, 2007, 7 ( 4 ) : 1027-1031.
  • 9Nambiar A, Duquesnoy RJ, Adams S, et al. HLAMatch- maker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thromtxoytopenic patients [ J ]. Blood, 2006, 107(4): 1680-1687.
  • 10Duquesnoy RJ. Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications [ J ]. Tissue Antigens, 2011, 77(6): 525-534.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部